123 related articles for article (PubMed ID: 17765442)
1. Metastatic esophageal adenocarcinoma presenting in the iris.
Lee WB; Sy HM; Filip DJ; Grossniklaus HE
Am J Ophthalmol; 2007 Sep; 144(3):477-9. PubMed ID: 17765442
[TBL] [Abstract][Full Text] [Related]
2. Locally advanced esophageal adenocarcinoma: response to neoadjuvant chemotherapy and survival predicted by ([18F])FDG-PET/CT.
Kauppi JT; Oksala N; Salo JA; Helin H; Karhumäki L; Kemppainen J; Sihvo EI; Räsänen JV
Acta Oncol; 2012 May; 51(5):636-44. PubMed ID: 22208782
[TBL] [Abstract][Full Text] [Related]
3. Iris metastasis of esophageal cancer.
Ichiki Y; Morita M; Yano K; Sugio K; Yasumoto K; Hirose N
Ann Thorac Surg; 2005 May; 79(5):1782-4. PubMed ID: 15854985
[TBL] [Abstract][Full Text] [Related]
4. Metastatic lung adenocarcinoma to the iris mimicking Cogan-Reese syndrome.
Harvey BJ; Grossniklaus HE; Traynor MP; Sarkisian SR; Stone DU
J Glaucoma; 2012; 21(8):567-9. PubMed ID: 21897284
[TBL] [Abstract][Full Text] [Related]
5. A phase I study of docetaxel, oxaliplatin, and capecitabine in patients with metastatic gastroesophageal cancer.
Evans D; Miner T; Akerman P; Millis R; Jean M; Kennedy T; Safran H
Am J Clin Oncol; 2007 Aug; 30(4):346-9. PubMed ID: 17762433
[TBL] [Abstract][Full Text] [Related]
6. Activity of oxaliplatin plus capecitabine (CapeOx) with lapatinib for metastatic colorectal cancer: results from two patients treated on a clinical study.
Mohammed TA; Dennie T; Holen KD
Clin Adv Hematol Oncol; 2011 Jun; 9(6):492-500. PubMed ID: 21841751
[No Abstract] [Full Text] [Related]
7. Bilateral acute ptosis leading to the diagnosis of a presumed metastatic gastric adenocarcinoma.
Mutyala V; Bains S; Patil C; Madhavarao B
Orbit; 2012 Apr; 31(2):134-6. PubMed ID: 22489859
[TBL] [Abstract][Full Text] [Related]
8. A phase I study of docetaxel, oxaliplatin, & capecitabine (DOC) as first-line therapy of patients with locally advanced or metastatic adenocarcinoma of stomach and GE junction.
Malik I; Bernal P; Byrd J
Cancer Invest; 2010 Oct; 28(8):833-8. PubMed ID: 20839949
[TBL] [Abstract][Full Text] [Related]
9. Red lesions of the iris, choroid, and skin secondary to metastatic carcinoma of the thyroid: a review.
Arat YO; Boniuk M
Surv Ophthalmol; 2007; 52(5):523-8. PubMed ID: 17719373
[TBL] [Abstract][Full Text] [Related]
10. Metastatic prostatic adenocarcinoma mimicking inflammatory breast carcinoma: a case report.
Njiaju UO; Truica CI
Clin Breast Cancer; 2010 Feb; 10(1):E3-5. PubMed ID: 20133250
[TBL] [Abstract][Full Text] [Related]
11. Validation of the Royal Marsden hospital prognostic index in advanced esophagogastric cancer using individual patient data from the REAL 2 study.
Chau I; Ashley S; Cunningham D
J Clin Oncol; 2009 Jul; 27(19):e3-4. PubMed ID: 19470917
[No Abstract] [Full Text] [Related]
12. Phase II study of capecitabine and oxaliplatin for advanced adenocarcinoma of the small bowel and ampulla of Vater.
Overman MJ; Varadhachary GR; Kopetz S; Adinin R; Lin E; Morris JS; Eng C; Abbruzzese JL; Wolff RA
J Clin Oncol; 2009 Jun; 27(16):2598-603. PubMed ID: 19164203
[TBL] [Abstract][Full Text] [Related]
13. Phase I/II trial of preoperative oxaliplatin, docetaxel, and capecitabine with concurrent radiation therapy in localized carcinoma of the esophagus or gastroesophageal junction.
Spigel DR; Greco FA; Meluch AA; Lane CM; Farley C; Gray JR; Clark BL; Burris HA; Hainsworth JD
J Clin Oncol; 2010 May; 28(13):2213-9. PubMed ID: 20351330
[TBL] [Abstract][Full Text] [Related]
14. Capecitabine, epirubicin and cisplatin in the treatment of oesophagogastric adenocarcinoma.
Corporaal S; Smit WM; Russel MG; van der Palen J; Boot H; Legdeur MC
Neth J Med; 2006 May; 64(5):141-6. PubMed ID: 16702612
[TBL] [Abstract][Full Text] [Related]
15. Nonsurgical management of esophageal adenocarcinoma.
Gujral DM; Hawkins MA; Leonulli BG; Ashley S; Chau I; Cunningham D; Tait D
Clin Colorectal Cancer; 2011 Sep; 10(3):165-70. PubMed ID: 21855037
[TBL] [Abstract][Full Text] [Related]
16. Esophageal adenocarcinoma after laparoscopic gastric band placement for obesity.
Stauffer JA; Mathew J; Odell JA
Dis Esophagus; 2011 Jan; 24(1):E8-10. PubMed ID: 21166738
[TBL] [Abstract][Full Text] [Related]
17. Phase III trial in metastatic gastroesophageal adenocarcinoma with fluorouracil, leucovorin plus either oxaliplatin or cisplatin: a study of the Arbeitsgemeinschaft Internistische Onkologie.
Al-Batran SE; Hartmann JT; Probst S; Schmalenberg H; Hollerbach S; Hofheinz R; Rethwisch V; Seipelt G; Homann N; Wilhelm G; Schuch G; Stoehlmacher J; Derigs HG; Hegewisch-Becker S; Grossmann J; Pauligk C; Atmaca A; Bokemeyer C; Knuth A; Jäger E;
J Clin Oncol; 2008 Mar; 26(9):1435-42. PubMed ID: 18349393
[TBL] [Abstract][Full Text] [Related]
18. Acute myeloid leukemia secondary to oxaliplatin treatment for esophageal cancer.
Damodaran S; Bellavia T; Sait SN; Wang ES; Wetzler M; Khushalani NI
Clin Colorectal Cancer; 2012 Jun; 11(2):151-4. PubMed ID: 22133502
[No Abstract] [Full Text] [Related]
19. Alpha-fetoprotein expressing metastastic adenocarcinoma of the esophago-gastric junction responding favorably to capecitabine and oxaliplatin.
Kripp M; Ströbel P; Dinter D; Lukan N; Hochhaus A; Hofheinz RD
Anticancer Drugs; 2009 Jan; 20(1):75-8. PubMed ID: 19343004
[TBL] [Abstract][Full Text] [Related]
20. Phase I study of docetaxel, oxaliplatin and capecitabine (TEX) as first line therapy to patients with advanced gastro-oesophageal cancer.
Andersen M; Schønnemann KR; Yilmaz M; Jensen HA; Vestermark LW; Pfeiffer P
Acta Oncol; 2010 Nov; 49(8):1246-52. PubMed ID: 20429725
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
